Mitiglinide
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Mitiglinide?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Mitiglinide (INN,[1] trade name Glufast) is a drug for the treatment of type 2 diabetes.[2]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Glufast |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth (tablets) |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H25NO3 |
Molar mass | 315.413 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close
Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.